Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

Crow RA, Hart KA, McDermott MP, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Hirtz D, Lochmuller H, Straub V, Ciafaloni E, Shieh PB, Spinty S, Childs AM, Manzur AY, Morandi L, Butterfield RJ, Horrocks I, Roper H, Flanigan KM, Kuntz NL, Mah JK, Morrison L, Darras BT, von der Hagen M, Schara U, Wilichowski E, Mongini T, McDonald CM, Vita G, Barohn RJ, Finkel RS, Wicklund M, McMillan HJ Jr, Hughes I, Pegoraro E, Bryan Burnette W, Howard JF, Thangarajh M, Campbell C, Griggs RC, Bushby K, Guglieri M.

Trials. 2018 May 10;19(1):291. doi: 10.1186/s13063-018-2645-0. Review.

2.

The Interaction of Pre-programmed Eye Movements With the Vestibulo-Ocular Reflex.

Haggerty SE, King WM.

Front Syst Neurosci. 2018 Mar 9;12:4. doi: 10.3389/fnsys.2018.00004. eCollection 2018.

3.

Vestibular short-latency evoked potential abolished by low-frequency noise exposure in rats.

Stewart CE, Kanicki AC, Altschuler RA, King WM.

J Neurophysiol. 2018 Feb 1;119(2):662-667. doi: 10.1152/jn.00668.2017. Epub 2017 Nov 8.

4.

Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides.

Handelsman JA, Nasr SZ, Pitts C, King WM.

Pediatr Pulmonol. 2017 Sep;52(9):1157-1162. doi: 10.1002/ppul.23763. Epub 2017 Jul 24.

5.

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald CM, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC.

Contemp Clin Trials. 2017 Jul;58:34-39. doi: 10.1016/j.cct.2017.04.008. Epub 2017 Apr 24.

6.

One clinic's experience with carbon fiber orthoses in neuromuscular disease.

Mnatsakanian A, Kissel JT, Terry P, King WM.

Muscle Nerve. 2017 Feb;55(2):202-205. doi: 10.1002/mus.25233. Epub 2016 Aug 17.

PMID:
27356926
7.

Vestibular dysfunction in the adult CBA/CaJ mouse after lead and cadmium treatment.

Klimpel KE, Lee MY, King WM, Raphael Y, Schacht J, Neitzel RL.

Environ Toxicol. 2017 Mar;32(3):869-876. doi: 10.1002/tox.22286. Epub 2016 Jun 3.

8.

Health Behavior Change Interventions for Teenage and Young Adult Cancer Survivors: A Systematic Review.

Pugh G, Gravestock HL, Hough RE, King WM, Wardle J, Fisher A.

J Adolesc Young Adult Oncol. 2016 Jun;5(2):91-105. doi: 10.1089/jayao.2015.0042. Epub 2016 Feb 12. Review.

PMID:
26871647
9.

Monothermal Caloric Screening to Improve Healthcare Value.

Thatcher AL, Beckerman ML, Telian SA, King WM.

Ear Hear. 2016 May-Jun;37(3):e188-93. doi: 10.1097/AUD.0000000000000262.

PMID:
26745280
10.

Mice with conditional deletion of Cx26 exhibit no vestibular phenotype despite secondary loss of Cx30 in the vestibular end organs.

Lee MY, Takada T, Takada Y, Kappy MD, Beyer LA, Swiderski DL, Godin AL, Brewer S, King WM, Raphael Y.

Hear Res. 2015 Oct;328:102-12. doi: 10.1016/j.heares.2015.07.018. Epub 2015 Jul 29.

11.

Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45.

Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Howard MT, Day JW, McDonald C, Nicolas A, Le Rumeur E, Weiss RB, Flanigan KM; United Dystrophinopathy Project.

Ann Neurol. 2015 Apr;77(4):668-74. doi: 10.1002/ana.24365. Epub 2015 Mar 2.

12.

Characterization of diabetes risk factors in patients prescribed chronic statin therapy.

King WM 4th, Saseen JJ, Anderson SL.

Ther Adv Chronic Dis. 2014 Sep;5(5):206-11. doi: 10.1177/2040622314530460.

13.

Apixaban (eliquis) for stroke prevention in atrial fibrillation.

Beck RA, King WM 4th.

Am Fam Physician. 2014 Apr 15;89(8):672-5. No abstract available.

14.

Photoresponse diversity among the five types of intrinsically photosensitive retinal ganglion cells.

Zhao X, Stafford BK, Godin AL, King WM, Wong KY.

J Physiol. 2014 Apr 1;592(7):1619-36. doi: 10.1113/jphysiol.2013.262782. Epub 2014 Jan 6.

15.

Bent spine syndrome as an early manifestation of myotonic dystrophy type 1.

Lawson VH, King WM, Arnold WD.

J Clin Neuromuscul Dis. 2013 Dec;15(2):58-62. doi: 10.1097/CND.0b013e3182a3012d.

PMID:
24263032
16.

Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study.

King WM 4th, McDermott MT, Trujillo JM.

Diabetes Ther. 2013 Dec;4(2):375-84. doi: 10.1007/s13300-013-0036-9. Epub 2013 Aug 16.

17.

Skeletal health in Duchenne dystrophy: bone-size and subcranial dual-energy X-ray absorptiometry analyses.

King WM, Kissel JT, Visy D, Goel PK, Matkovic V.

Muscle Nerve. 2014 Apr;49(4):512-9. doi: 10.1002/mus.23963. Epub 2014 Feb 26.

PMID:
23893858
18.

SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy.

Kissel JT, Elsheikh B, King WM, Freimer M, Scott CB, Kolb SJ, Reyna SP, Crawford TO, Simard LR, Krosschell KJ, Acsadi G, Schroth MK, D'Anjou G, LaSalle B, Prior TW, Sorenson S, Maczulski JA, Swoboda KJ; Project Cure Spinal Muscular Atrophy Investigators Network.

Muscle Nerve. 2014 Feb;49(2):187-92.

19.

Scaling of compensatory eye movements during translations: virtual versus real depth.

Dits J, King WM, van der Steen J.

Neuroscience. 2013 Aug 29;246:73-81. doi: 10.1016/j.neuroscience.2013.04.029. Epub 2013 Apr 30.

20.

LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.

Flanigan KM, Ceco E, Lamar KM, Kaminoh Y, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Gappmaier E, Howard MT, Day JW, McDonald C, McNally EM, Weiss RB; United Dystrophinopathy Project.

Ann Neurol. 2013 Apr;73(4):481-8. doi: 10.1002/ana.23819. Epub 2013 Feb 20.

Supplemental Content

Loading ...
Support Center